First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones
- PMID: 36205340
- PMCID: PMC10089227
- DOI: 10.1097/JU.0000000000002864
First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones
Abstract
Purpose: Our goal was to test transcutaneous focused ultrasound in the form of ultrasonic propulsion and burst wave lithotripsy to reposition ureteral stones and facilitate passage in awake subjects.
Materials and methods: Adult subjects with a diagnosed proximal or distal ureteral stone were prospectively recruited. Ultrasonic propulsion alone or with burst wave lithotripsy was administered by a handheld transducer to awake, unanesthetized subjects. Efficacy outcomes included stone motion, stone passage, and pain relief. Safety outcome was the reporting of associated anticipated or adverse events.
Results: Twenty-nine subjects received either ultrasonic propulsion alone (n = 16) or with burst wave lithotripsy bursts (n = 13), and stone motion was observed in 19 (66%). The stone passed in 18 (86%) of the 21 distal ureteral stone cases with at least 2 weeks follow-up in an average of 3.9±4.9 days post-procedure. Fragmentation was observed in 7 of the burst wave lithotripsy cases. All subjects tolerated the procedure with average pain scores (0-10) dropping from 2.1±2.3 to 1.6±2.0 (P = .03). Anticipated events were limited to hematuria on initial urination post-procedure and mild pain. In total, 7 subjects had associated discomfort with only 2.2% (18 of 820) propulsion bursts.
Conclusions: This study supports the efficacy and safety of using ultrasonic propulsion and burst wave lithotripsy in awake subjects to reposition and break ureteral stones to relieve pain and facilitate passage.
Keywords: calculi; lithotripsy; ultrasound; urolithiasis.
Conflict of interest statement
Conflict of Interest: MB, BC, BD, and MS have consulting agreements with and equity in SonoMotion, Inc., which has licensed this technology from the University of Washington for commercialization. RMS: American Urological Association, Elsevier Publishing (Campbells Urology). ISM: Bard BD, Perceus Inc. MD: Philips Medical Imaging, General Electric Healthcare.
Figures
Comment in
-
Editorial Comment.J Urol. 2022 Nov;208(5):1082. doi: 10.1097/JU.0000000000002864.01. Epub 2022 Nov 1. J Urol. 2022. PMID: 36205345 No abstract available.
-
First Series Using Ultrasonic Propulsion and Burst Wave Lithotripsy to Treat Ureteral Stones. Letter.J Urol. 2023 Feb;209(2):325-326. doi: 10.1097/JU.0000000000003060. Epub 2022 Nov 16. J Urol. 2023. PMID: 36383751 No abstract available.
References
-
- Feinstein L Kidney Stones Washington, DC: Urologic Diseases in America. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases US Government Printing Office; NIH Publication No. 20172018:12–7865.
-
- Assimos D, Krambeck A, Miller NL, et al. Surgical management of stones: American Urological Association/Endourological Society guideline, PART II. J Urol 2016;196(4):1161–1169. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
